Dr. Goff believes that the COVID-19 pandemic has provided a real-life example of the type of threat that AMR poses to our health.
COVID-19 and Antimicrobial Resistance: Dual Health Threats
Each year, more than 700,000 people lose their lives to drug-resistant infections, and this number could climb to 10 million by the year 2050 if nothing is done help combat it. Now, the COVID-19 pandemic is exacerbating the problem.
“On the Frontlines” Webinar Series, November 19 – Sepsis vs. Stewardship: Are They Compatible?
Dr. Septimus will discuss the potential benefits and harms of antibiotics, as well as the value of antimicrobial stewardship when it comes to improving outcomes of patients suffering from sepsis.
Acute Kidney Injury is a Frequent Complication of COVID-19
Clinical presentation of kidney involvement from COVID-19 can range from mild proteinuria to progressive AKI, requiring renal replacement therapy (RRT).
The Value of Diagnostics in Combatting Antimicrobial Resistance – A Public Health Problem
At this year’s World Anti-Microbial Resistance Congress, Dr. Tristan Timbrook delivered a...
Lindsay Denny Discusses the Critical Role of WASH in Preventing Infectious Diseases and Fighting Antimicrobial Resistance
WASH, which stands for water, sanitation, and hygiene, are basic...